A group of UK researchers, leading biopharmaceutical companies and industry groups have called on the country's National Health Service to take a dramatic step forward by introducing genetic profiling of every patient's cancer following diagnosis and during treatment.
UK push to lead the world on genetic profiling of cancer patients
August 11, 2022 Latest NewsBioPharma 
		Latest Video
New Stories
- 
					
						The 'Dispatched' Week in Review Podcast - 31 OctoberOctober 31, 2025 - - Podcast
- 
					
						Aroa Biosurgery appoints Paul Shearer to Board as John Pinion retiresOctober 31, 2025 - - Australian Biotech
- 
					
						Immuron provides update on U.S. clinical trials for Travelan and IMM-529October 31, 2025 - - Australian Biotech
- 
					
						Firebrick Pharma launches new Nasodine Throat Spray for international marketsOctober 31, 2025 - - Australian Biotech
- 
					
						Amplia Therapeutics begins trading on U.S. OTCQB Venture MarketOctober 31, 2025 - - Australian Biotech
- 
					
						DHL Supply Chain opens New Zealand’s most advanced life sciences and healthcare logistics facilityOctober 31, 2025 - - Latest News
- 
					
						The continued 'false framing' aims to make us feel guilty for wanting more on healthOctober 31, 2025 - - Latest News
